Request Sample Inquiry
Diabetic Neuropathy Market

Diabetic Neuropathy Market

Diabetic Neuropathy Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

240

Base Year:

2023

Date

May - 2024

Format:

PDF XLS PPT

Report Code:

VMR-2473

Segments Covered
  • By Disorder Type By Disorder Type Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy
  • By Treatment Type By Treatment Type Drugs, Radiotherapy, Physiotherapy
  • By Distribution Channel By Distribution Channel Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 4.17 Billion
Revenue 2032Revenue 2032: USD 7.8 Billion
Revenue CAGRRevenue CAGR (2024 - 2032): 7.2%
Fastest Growing Region Fastest Growing Region (2024 - 2032) Europe
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Diabetic Neuropathy Market - Segment Analysis
    1. Overview
    2. Global Diabetic Neuropathy Market, 2016 - 2028 (USD Million)
    3. Global Diabetic Neuropathy Market - by Disorder Type
      1. By Peripheral Neuropathy
      2. By Autonomic Neuropathy
      3. By Proximal Neuropathy
      4. By Focal Neuropathy
    4. Global Diabetic Neuropathy Market - by Treatment Type
      1. By Drugs
      2. By Radiotherapy
      3. By Physiotherapy
    5. Global Diabetic Neuropathy Market - by Distribution Channel
      1. By Hospitals Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
    6. Global Diabetic Neuropathy Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Diabetic Neuropathy Market - Segment Analysis
    1. Overview
    2. North America Diabetic Neuropathy Market, 2016 - 2028 (USD Million)
    3. North America Diabetic Neuropathy Market, by Disorder Type
      1. By Peripheral Neuropathy
      2. By Autonomic Neuropathy
      3. By Proximal Neuropathy
      4. By Focal Neuropathy
    4. North America Diabetic Neuropathy Market, by Treatment Type
      1. By Drugs
      2. By Radiotherapy
      3. By Physiotherapy
    5. North America Diabetic Neuropathy Market, by Distribution Channel
      1. By Hospitals Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
    6. North America Diabetic Neuropathy Market, by Country
      1. U.S.
        1. U.S. Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. U.S. Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. U.S. Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      2. Canada
        1. Canada Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. Canada Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. Canada Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      3. Mexico
        1. Mexico Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. Mexico Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. Mexico Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
  5. Europe Diabetic Neuropathy Market - Segment Analysis
    1. Overview
    2. Europe Diabetic Neuropathy Market, 2016 - 2028 (USD Million)
    3. Europe Diabetic Neuropathy Market, by Disorder Type
      1. By Peripheral Neuropathy
      2. By Autonomic Neuropathy
      3. By Proximal Neuropathy
      4. By Focal Neuropathy
    4. Europe Diabetic Neuropathy Market, by Treatment Type
      1. By Drugs
      2. By Radiotherapy
      3. By Physiotherapy
    5. Europe Diabetic Neuropathy Market, by Distribution Channel
      1. By Hospitals Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
    6. Europe Diabetic Neuropathy Market, by Country
      1. Germany
        1. Germany Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. Germany Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. Germany Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      2. UK
        1. UK Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. UK Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. UK Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      3. France
        1. France Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. France Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. France Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      4. Spain
        1. Spain Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. Spain Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. Spain Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      5. Italy
        1. Italy Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. Italy Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. Italy Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      6. BENELUX
        1. BENELUX Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. BENELUX Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. BENELUX Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      7. Rest of Europe
        1. Rest Of Europe Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. Rest Of Europe Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. Rest Of Europe Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
  6. Asia Pacific Diabetic Neuropathy Market - Segment Analysis
    1. Overview
    2. Asia Pacific Diabetic Neuropathy Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Diabetic Neuropathy Market, by Disorder Type
      1. By Peripheral Neuropathy
      2. By Autonomic Neuropathy
      3. By Proximal Neuropathy
      4. By Focal Neuropathy
    4. Asia Pacific Diabetic Neuropathy Market, by Treatment Type
      1. By Drugs
      2. By Radiotherapy
      3. By Physiotherapy
    5. Asia Pacific Diabetic Neuropathy Market, by Distribution Channel
      1. By Hospitals Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
    6. Asia Pacific Diabetic Neuropathy Market, by Country
      1. China
        1. China Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. China Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. China Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      2. Japan
        1. Japan Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. Japan Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. Japan Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      3. India
        1. India Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. India Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. India Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      4. South Korea
        1. South Korea Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. South Korea Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. South Korea Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      5. South East Asia
        1. South East Asia Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. South East Asia Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. South East Asia Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. Rest of Asia Pacific Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. Rest of Asia Pacific Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
  7. Latin America Diabetic Neuropathy Market - Segment Analysis
    1. Overview
    2. Latin America Diabetic Neuropathy Market, 2016 - 2028 (USD Million)
    3. Latin America Diabetic Neuropathy Market, by Disorder Type
      1. By Peripheral Neuropathy
      2. By Autonomic Neuropathy
      3. By Proximal Neuropathy
      4. By Focal Neuropathy
    4. Latin America Diabetic Neuropathy Market, by Treatment Type
      1. By Drugs
      2. By Radiotherapy
      3. By Physiotherapy
    5. Latin America Diabetic Neuropathy Market, by Distribution Channel
      1. By Hospitals Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
    6. Latin America Diabetic Neuropathy Market, by Country
      1. Brazil
        1. Brazil Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. Brazil Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. Brazil Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      2. Argentina
        1. Argentina Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. Argentina Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. Argentina Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      3. Rest of Latin America
        1. Rest of Latin America Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. Rest of Latin America Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. Rest of Latin America Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
  8. Middle East & Africa Diabetic Neuropathy Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Diabetic Neuropathy Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Diabetic Neuropathy Market, by Disorder Type
      1. By Peripheral Neuropathy
      2. By Autonomic Neuropathy
      3. By Proximal Neuropathy
      4. By Focal Neuropathy
    4. Middle East & Africa Diabetic Neuropathy Market, by Treatment Type
      1. By Drugs
      2. By Radiotherapy
      3. By Physiotherapy
    5. Middle East & Africa Diabetic Neuropathy Market, by Distribution Channel
      1. By Hospitals Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
    6. Middle East & Africa Diabetic Neuropathy Market, by Country
      1. GCC Countries
        1. GCC Countries Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. GCC Countries Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. GCC Countries Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      2. South Africa
        1. South Africa Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. South Africa Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. South Africa Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Diabetic Neuropathy Market, By Disorder Type
          1. By Peripheral Neuropathy
          2. By Autonomic Neuropathy
          3. By Proximal Neuropathy
          4. By Focal Neuropathy
        2. Rest of Middle East & Africa Diabetic Neuropathy Market, By Treatment Type
          1. By Drugs
          2. By Radiotherapy
          3. By Physiotherapy
        3. Rest of Middle East & Africa Diabetic Neuropathy Market, By Distribution Channel
          1. By Hospitals Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Abbott Laboratories (U.S.)
    2. Pfizer Inc. (U.S.)
    3. Eli Lilly and Company (U.S.)
    4. Glenmark Pharmaceuticals Ltd. (India)
    5. Janssen Pharmaceuticals (Belgium)
    6. Boehringer Ingelheim International GmbH (Germany)
    7. NeuroMetrix Inc. (U.S.)
    8. Astellas Pharma Inc. (Japan)
    9. Novartis AG (Switzerland)
    10. Lupin Ltd. (India)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 16-May-2024
NeuroMetrix Study Highlights Breakthroughs in Diagnosing Diabetic Peripheral Neuropathy
FAQ
Frequently Asked Question

  • The global Diabetic Neuropathy valued at USD 4.17 Billion in 2023 and is expected to reach USD 7.8 Billion in 2032 growing at a CAGR of 7.2%.

  • The prominent players in the market are Abbott Laboratories (U.S.), Pfizer Inc. (U.S.), Eli Lilly and Company (U.S.), Glenmark Pharmaceuticals Ltd. (India), Janssen Pharmaceuticals (Belgium), Boehringer Ingelheim International GmbH (Germany), NeuroMetrix Inc. (U.S.), Astellas Pharma Inc. (Japan), Novartis AG (Switzerland), Lupin Ltd. (India).

  • The market is project to grow at a CAGR of 7.2% between 2024 and 2032.

  • The driving factors of the Diabetic Neuropathy include

  • North America was the leading regional segment of the Diabetic Neuropathy in 2023.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy